Healthcare Triangle Secures $755,000 Through Warrant Exercise Agreements

Healthcare Triangle, Inc. (Nasdaq: HCTI), a digital transformation solutions provider for healthcare and life sciences, has entered into warrant exercise agreements with existing accredited and institutional investors that will generate approximately $755,000 in gross proceeds. The transaction involves the immediate exercise of outstanding warrants for 377,702 shares of common stock, with the exercising holders receiving new warrants in a private placement for the same number of shares at an exercise price of $3.00 per share.

The warrant inducement arrangement represents a strategic financial maneuver that provides immediate capital infusion while maintaining investor participation through new warrant instruments. In connection with the exercise of existing warrants, the company agreed to reduce the exercise price from $20.92 to $2.00 per share, making the transaction more attractive to current warrant holders. The new warrants issued become immediately exercisable upon issuance and carry a five-year expiration term, providing long-term investment opportunities for participating institutions.

The transaction, expected to close on October 6, 2025, demonstrates Healthcare Triangle's proactive approach to capital management during a period of significant transformation in healthcare technology. The $755,000 in gross proceeds, excluding potential future proceeds from new warrant exercises and before deducting financial advisor fees and expenses, strengthens the company's balance sheet at a time when healthcare organizations are increasingly relying on digital solutions to improve patient outcomes and operational efficiency.

WallachBeth Capital is serving as financial advisor for the warrant inducement transaction, bringing specialized expertise in structuring such financial arrangements. This capital raise occurs as Healthcare Triangle continues to expand its portfolio of certified healthcare technology solutions, including its HITRUST-certified CloudEz™ and DataEz™ platforms that help healthcare organizations better utilize data and information technologies.

The funding comes at a critical juncture for the healthcare technology sector, where organizations face increasing pressure to modernize infrastructure while maintaining compliance with stringent regulatory requirements. Healthcare Triangle's focus on digital transformation encompassing cloud, security, compliance, and data lifecycle management positions the company to address immediate industry needs while preparing for future competitive threats. The additional capital provides resources to accelerate development of solutions that support healthcare providers, payers, and pharmaceutical companies in their digital evolution journeys.

For investors and industry observers, this transaction signals Healthcare Triangle's commitment to maintaining financial flexibility while executing its growth strategy in the rapidly evolving healthcare technology landscape. The warrant structure balances immediate capital needs with long-term shareholder value creation, reflecting a measured approach to financing that aligns with the company's position as a trusted partner for healthcare organizations navigating complex digital transformation challenges.